Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,161
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
for
Acute Kidney Injury
Location: New Haven CT, Baltimore MD, Cleveland OH, Nashville TN,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT05805709
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: New Haven CT, Hartford CT, Valhalla NY, Mineola NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
for
Heart Failure With Reduced Ejection Fraction
Location: New Haven CT, Chicago IL, Aurora CO, Salt Lake City UT,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18+
Code: NCT06526988
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: New Haven CT, Stony Brook NY, New Hyde Park NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: New Haven CT, Hartford CT, Stony Brook NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: New Haven CT, Hartford CT, Valhalla NY, The Bronx NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
for
Heart Failure, Diuretic Resistance
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06209359
Phase 1, Recruiting
Mechanisms of Diuretic Resistance in Heart Failure, Aim 2
for
Heart Failure
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05753059
Phase 1, Recruiting
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
for
Stress Urinary Incontinence, Pelvic Organ Prolapse
Location: New Haven CT, Philadelphia PA, Pittsburgh PA, Durham NC
Sponsor: Ethicon, Inc.
Sex: Female
Age: 21+
Code: NCT04829175
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: New Haven CT, West Haven CT, Stony Brook NY, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase 2, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
for
Opioid Use Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 25 - 55
Code: NCT06160284
Phase 1, Recruiting
The Recovery in Stroke Using PAP Study
for
Ischemic Stroke, Obstructive Sleep Apnea
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT04130503
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: New Haven CT, West Haven CT, Stony Brook NY, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase 2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: New Haven CT, Hartford CT, Trumbull CT, Montvale NJ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase 2, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study